Navigation Links
BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010
Date:5/6/2010

span>.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.

This press release contains forward-looking statements about Amylin, Lilly and Alkermes. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that BYDUREON may not be approved by the FDA in a timely manner or at all; the companies' response to the complete response letter may not satisfy the FDA; the FDA may request additional information prior to
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
5. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
6. AEterna Zentaris Announces Outcome of Managements Strategic Review
7. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
8. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
9. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
10. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
11. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Secretary of State John Kerry today presided ... Mary-Dell Chilton , Ph.D., was named a laureate ... is the foremost international award recognizing individuals who have ... availability of food in the world. Dr. ... biotechnology discoveries that unlocked the key to plant cell ...
(Date:6/19/2013)... , June 19, 2013  Continuing its long ... infarction (MI), Beckman Coulter , Inc. announces the ... its new Access AccuTnI+3 troponin I assay for use ... "Clinicians have depended on Beckman Coulter,s troponin ... AccuTnI+3 assay has the proven performance to continue providing ...
(Date:6/19/2013)... India , June 19, ... Bharat Book Bureau presents Innovative ... and Formulation Technology Licensing Opportunities ... http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html ) There ... or controlled release drugs approved ...
(Date:6/19/2013)... MN (PRWEB) June 19, 2013 Express ... abuse tests, today announced that it has received Class ... market and sell its DrugCheck® NxStep Onsite Drug ... use of the rapid screening device in near-patient settings, ... Drug Screen Cup received Health Canada Class III approval ...
Breaking Biology Technology:Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
... 2012  Superior Controls, Inc. has been named "System ... magazine.  Each year, the worldwide competition recognizes the ... expertise, business skills and customer satisfaction. A panel ... from industrial systems integrators throughout the world. 
 ...
...  Healthpoint Biotherapeutics today announced that Travis E. Baugh, President ... President, Strategic and Commercial Development, will present an overview ... pipeline at the upcoming J.P. Morgan Healthcare Conference. The ... am (PST) at the Westin St. Francis Hotel in ...
... WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, ... corporate presentation at the 5 th Annual OneMedForum ... San Francisco, Calif., January 9-12, 2012. The ... 2012 beginning at 10:00 a.m. Pacific Time.  The presentation ...
Cached Biology Technology:Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine 2WaferGen to Present Corporate Overview at 5th Annual OneMedForum San Francisco 2012 2
(Date:6/18/2013)... Department,s National Renewable Energy Laboratory (NREL), and the ... describing a novel cellulose-degrading enzyme from a marine ... as the gribble. , Gribbles are biologically ... to produce their own enzymes instead of using ... eat. New biomass-degrading enzymes from novel sources such ...
(Date:6/18/2013)... a very large "dead zone" in the Gulf of ... the Chesapeake Bay this year, based on several NOAA-supported ... Michigan, Louisiana State University, and the Louisiana Universities ... Mexico hypoxic "dead" zone will be between 7,286 and ... ten largest recorded. That would range from an area ...
(Date:6/18/2013)... D.C. June 18, 2013 Joshua Obar, Ph.D., ... has been honored with a 2013 ICAAC Young Investigator ... regulation of immunological memory responses to infection. , ... University in 2001 and went on to complete his ... 2006. He performed his Ph.D. thesis research in ...
Breaking Biology News(10 mins):Novel enzyme from tiny gribble could prove a boon for biofuels research 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4The American Society for Microbiology honors Joshua Obar 2
... Healthy ecosystems that provide people with essential natural ... biological diversity, underscoring that conserving one also protects the ... Titled Global Conservation of Biodiversity and Ecosystem Services, the ... priority for conservation efforts. It shows that more ...
... will receive the 2007 EMBO Installation Grants, assisting them ... Croatia, the Czech Republic, Hungary, Poland, Portugal and Turkey. ... since the European Molecular Biology Organization (EMBO) introduced the ... annually and aim to strengthen science in selected member ...
... growth, climate change, high energy prices, globalization, and ... markets, and consumption, according to a new report ... As a result, global food demand and prices ... nutrition of poor people in developing countries. The ...
Cached Biology News:New study finds biodiversity conservation secures ecosystem services for people 2EMBO Installation Grants help 9 scientists set up in Europe 2Rising food prices threaten world's poor people 2Rising food prices threaten world's poor people 3Rising food prices threaten world's poor people 4
Aldolase A (N-15)...
... Rabbit polyclonal NPY Y2 Receptor antiserum ... at the spinal level and is currently being ... in both rat and mouse and appears to ... is seen in rat. For full characterizarion in ...
Black Polypropylene 384 Round Well Plate 70/Box...
... activated ,• Eliminates nonspecific products due ... Excellent specificity allows extension through DNA regions ... Leaves an 'A' overhang ,TEMPase ... GeneChoice DNA Polymerase that remains inactive ...
Biology Products: